SCHEMBL4788025

SCHEMBL4788025

CCOC(=O)C1=C(C)N(C(C)OCC)C(c2cccc(OC)c2OC)N1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.44
ALDH1A1 P00352 4/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
HSD17B10 Q99714 4/20 0.42
KDM4E B2RXH2 3/20 0.42
CASP1 P29466 1/20 0.42
DHFR P00374 1/20 0.41
MAPT P10636 4/20 0.41
GAA P10253 3/20 0.41
TP53 P04637 1/20 0.41
HTT P42858 1/20 0.41
TSHR P16473 2/20 0.41
GLA P06280 1/20 0.41
LMNA P02545 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALOX15 P16050 1/20 0.38
CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4788575 0.78 GAA (0.49) ALDH1A1CYP2C9CYP2C19HSD17B10KDM4E
SCHEMBL4788014 0.65 MAPT (0.41) PKMALDH1A1MEN1KMT2AHSD17B10
SCHEMBL7688461 0.65 KMT2A (0.65) ALDH1A1MEN1KMT2AHSD17B10KDM4E
SCHEMBL27707738 0.65 NFE2L2 (0.49) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL10112995 0.62 ALDH1A1 (0.66) ALDH1A1CYP2C9CYP2C19MEN1KMT2A
SCHEMBL10280120 0.62 DHFR (0.53) PKMALDH1A1CYP2C9CYP2C19MEN1
SCHEMBL490336 0.61 MAPT (0.44) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL21668045 0.61 KDM4E (0.42) PKMALDH1A1HSD17B10KDM4EGAA
SCHEMBL10455857 0.61 CA12 (0.63) ALDH1A1CYP2C9MEN1KMT2AKDM4E
SCHEMBL27681080 0.60 LMNA (0.49) ALDH1A1MEN1KMT2AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008111794-A1 4-METHYLIMIDAZOL-5-YLCARBONYLGUANIDINE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF THE ISCHEMIC HEART DISEASES CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA RESERACH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2008-09-18 WO disclosed